Serina Therapeutics, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Serina Therapeutics, Inc. (SER) is 9.73M

According to Serina Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 9.73M. This represents a change of -53.41% compared to the average of 20.88M of the last 4 quarters.

Serina Therapeutics, Inc. (SER) Historical Enterprise Value (quarterly & annually)

How has SER Enterprise Value performed in the past?

The mean historical Enterprise Value of Serina Therapeutics, Inc. over the last ten years is 67.62M. The current 9.73M Enterprise Value has changed -85.61% with respect to the historical average. Over the past ten years (40 quarters), SER's Enterprise Value was at its highest in in the March 2019 quarter at 136.02M. The Enterprise Value was at its lowest in in the March 2017 quarter at 0.

Serina Therapeutics, Inc. (SER) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Serina Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Serina Therapeutics, Inc. (SER) Average Enterprise Value

How has SER Enterprise Value performed in the past?

The current Enterprise Value of Serina Therapeutics, Inc. (SER) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Serina Therapeutics, Inc. (SER) Enterprise Value vs. Peers

How is SER’s Enterprise Value compared to its peers?

Serina Therapeutics, Inc.’s Enterprise Value is less than Genenta Science S.p.A. (13.99M), greater than Skye Bioscience, Inc. (-2055298.00), greater than Jupiter Neurosciences, Inc. (3.33M), greater than Aligos Therapeutics, Inc. (2.22M), greater than Barinthus Biotherapeutics plc (-18767734.00), less than INmune Bio, Inc. (22.40M), less than X4 Pharmaceuticals, Inc. (212.78M), less than Telomir Pharmaceuticals, Inc. Common Stock (63.68M), less than Grace Therapeutics, Inc. (17.16M), less than CEL-SCI Corporation (25.82M),

Build a custom stock screener for Serina Therapeutics, Inc. (SER) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Serina Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Serina Therapeutics, Inc. (SER) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Serina Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.